Bio-Wolford Pharmaceutical Group is a group of companies with a long history of experience in providing best technological process solutions to the pharmaceutical, Biotechnology and Cosmetic industries.

The plant has an annual capacity of more than 3 billion oral solid dosage formulations. With an enviable location on the easily accessible, the plant is a preferred destination for contract manufacturing and site variation for general category tablets, capsules and sachets.

The facility has been built in line with latest regulatory requirements with a view to comply with UK and European Manufacturing Law.

It is equipped with sophisticated UK & Europe Pharmaceutical Law automated machines at each step of manufacturing.

Our strength is the team with wide experience in internationally reputed environment including contract manufacturing related aspects.

Bio-Wolford Pharmaceutical Group is poised to be a leading destination in contract manufacturing space in UK and all over Europe.

Brand new unit matching all relevant norms of regulatory authorities.

• Dedicated contract manufacturing operations for regulated markets.
• No conflict of interests as Bio-Wolford Pharmaceutical Group present in the European & American market with own products or brands.
• Professional corporate set-up ensures efficient management of operations
• Relevant experience: Bio-Wolford Pharmaceutical Group has experience of regulatory processes ISO certification and UK Pharmaceutical Law aspects.
• Financially sound to support the investments required.
• Layout to match the regulatory requirements as per UK-FDA, WHO and other international regulatory agencies.
• Logical man and material movement to ensure unidirectional flow avoiding cris cross.
• Flexibility in operations, design of various parameters ensures quick changeover between products.
• Separate two lines, one for tablets and one for capsules, minimizing the risk of contamination or cross-contamination.